Oculoplastics News

SAN FRANCISCO — Orbital complications after dermal filler injection may be due to inadvertent direct injection or may occur latently after filler migration, according to a retrospective review of six such cases at the American Society of Ophthalmic Plastic and Reconstructive Surgery meeting.

SAN FRANCISCO — The people who are tapped for leadership in medical associations are those who demonstrate dependability and durability. In other words, they show up. Tamara R. Fountain, MD, has been showing up since beginning her career as an oculoplastic surgeon, not necessarily looking for leadership positions, but those opportunities found her all the same.

SAN FRANCISCO — Open globe injuries are associated with an increased risk for anxiety and depression, according to a poster at the American Society of Ophthalmic Plastic and Reconstructive Surgery meeting.

SAN FRANCISCO — At the American Society of Ophthalmic Plastic and Reconstructive Surgery meeting, Raymond Douglas, MD, PhD, of Cedars-Sinai Medical Center, discusses new data from the phase 3 OPTIC confirmatory clinical trial.

SAN FRANCISCO — The severity of lower eyelid festoons can be lessened with combined radiofrequency and microneedling, with a greater aesthetic impact noted in higher-grade conditions, according to a study.

SAN FRANCISCO — Patients undergoing upper eyelid blepharoplasty treated with fibrin glue after surgery experienced a significant reduction in bruising and bleeding-related complications, according to a speaker here.

Healio.com/OSN is the online home of Ocular Surgery News. In addition to housing the online version of OSN, Healio/OSN creates daily news, meeting news coverage, executive summaries of journal articles, perspectives, videos, blogs and podcasts. With the increasing importance of Healio as the online presence of Ocular Surgery News and the continuous growth that is taking place online, we decided it was a good time to boost the Healio/OSN editorial board presence in the ophthalmic community.

Vertical Pharmaceuticals, a subsidiary of Osmotica Pharmaceuticals, has submitted a new drug application to the FDA for RVL-1201, its acquired blepharoptosis treatment candidate, according to a press release.

The FDA on Monday granted priority review of the investigational medication teprotumumab for treatment of thyroid eye disease, also known as Graves’ orbitopathy according to a press release from Horizon Therapeutics.

COEUR D’ALENE, Idaho — At the Women in Ophthalmology Summer Symposium, Femida Kherani, MD, FRCSC, discusses her participation in an oculoplastics surgical wet lab where she reviewed her top pearls for topical skin care.